ClinicalTrials.gg

Drug

Remimazolam tosylate clinical trials

Also written Remimazolam Tosilate.

A product of Remimazolam; its studies count on that page too.

studies test it
21
open now
2
in phase 3
6
first study started
2013

Keep track of what changes. Save the remimazolam tosylate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

21 studies that test it; most in 2021 (5)

Studies that test remimazolam tosylate, by start year
YearStudies
20131
20142
20161
20171
20181
20191
20201
20215
20221
20233
20242
20252

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
6
Phase 3
6
Phase 4
4
No phase
4

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 15 · Other 6

Jiangsu HengRui Medicine Co., Ltd. (14) · RenJi Hospital (2) · The First Hospital of Hebei Medical University (1) · Tongji Hospital (1) · Sichuan Provincial People's Hospital (1) · Peking University People's Hospital (1) · Fujian Shengdi Pharmaceutical Co., Ltd. (1)

Studies

Open first, then newest update. How each study uses remimazolam tosylate is read from its arms, and is right about nine times in ten.

Testing it · 21

See all 21 studies that test remimazolam tosylate →

Given in every arm · 3 — remimazolam tosylate is usual care beside what is tested

Codes

What other systems call remimazolam tosylate · ClinicalTrials.gg INT015875

  • UNII (FDA) 9J7J08A8LTREMIMAZOLAM TOSYLATEConfirmed FDA, Wikidata
  • Wikidata Q27272625remimazolam tosylateConfirmed FDA, Wikidata
  • NCI Thesaurus C179563Remimazolam TosylateOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.